← Open Payments lookup

FLORENCE NGUH: Open Payments

NPI 1093258998 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,952 in 66 payments from 13 companies in 2025. Trend: 2023 $294 · 2024 $1,177 · 2025 $1,952

Food & beverage: $1,952
CompanyPaymentsAmount
ABBVIE INC.9$358
Otsuka America Pharmaceutical, Inc.4$279
Alkermes, Inc.13$266
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$256
Lundbeck LLC10$198
Axsome Therapeutics, Inc.4$182
Neurocrine BioSciences, Inc.2$162
Janssen Pharmaceuticals, Inc2$64
E.R. Squibb & Sons, L.L.C.3$56
Supernus Pharmaceuticals, Inc.3$53

Products named: VRAYLAR, ABILIFY MAINTENA, CAPLYTA, ARISTADA, Auvelity, INGREZZA, REXULTI, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.